Bailey Cooper, Ph.D. 2016

Bailey Cooper completed her Ph.D. in the Putnam Lab in 2016. Her research focused on the design, synthesis, and evaluation of polymers for nucleic acid delivery. 

After graduating, Cooper joined the faculty of Virginia Tech’s Biomedical Engineering and Mechanics Department as the university was developing a new undergraduate BME program. When the new major launched in the fall of 2018, she joined the Formulation Development Group (FDG) at Regeneron Pharmaceuticals, Inc. 

As a scientist in the late-stage process development sub-group within FDG, she now balances her time between the research and the development aspects of her job. This includes supporting process development efforts for late stage programs and building in-house capabilities (e.g. small-scale models and platforms). She leads late stage clinical and commercial programs ―performing risk assessments, evaluating the impact of manufacturing processes on a product’s critical quality attributes, then setting process parameters for large-scale manufacturing, approving Process Performance Qualification protocols and authoring reports supporting regulatory filings. She works closely with colleagues across Chemistry, Manufacturing and Control, as well as with partner companies and contract manufacturing organizations, both in the U.S. and Europe. 

Cooper also serves on her department’s Regulatory Review Team, editing technical documents and regulatory sections for Investigational New Drug and Biologics License Application filings, and has been involved in several initiatives to develop new templates for technology transfer documents and regulatory sections.

Cooper loves staying connected with Cornell and since graduating has done so by participating in the 2019 Careers Beyond Academia panel and spring 2020 M.Eng. Showcase, where she met many outstanding graduate students. She loves networking and giving back and has helped to facilitate two job offers to current Meinig School students.